Magnevist MRI Contrast Agent May Cause Hypersensitivity Reactions: FDA
Federal drug regulators are warning that some patients may have a hypersensitivity to Magnevist, an MRI contrast solution used to improve the outcome of MRI scans.
Tag Archives: Nephrogenic Fibrosing Dermopathy
-
-
NSF Cases Disappeared Following MRI Contrast Guidelines: Study
Restrictive guidelines put in place on gadolinium-based contrast agents (GBCAs) used during some MRI examinations appear to be working, according to the findings of U.S. researchers, who report that they…
-
GE Healthcare Omniscan Lawsuit Settled on Eve of Trial
The first trial over nephrogenic systemic fibrosis (NSF) from Omniscan, a gadolinium-based MRI contrast agent manufactured by GE Healthcare, was settled in a last minute deal reached the night before…
-
Nephrogenic Systemic Fibrosis Risk With New MRI Contrast To Be Reviewed
The FDA has asked a panel of outside experts to evaluate the risk of nephrogenic systemic fibrosis (NSF) with a new MRI contrasting agent proposed by Bayer AG.
-
Nephrogenic Systemic Fibrosis (NSF) Lawsuit Set For Trial January 2011
Trial has been schedule to begin early next year for a lawsuit involving allegations that a gadolinium-based MRI contrast agent led to the development of nephrogenic systemic fibrosis (NSF), a…
-
FDA Warns Not to Use Some MRI Contrast Agents With Kidney Patients
The FDA is banning the use of three major brands of MRI contrast agent on patients with kidney problems, and is forcing other manufacturers to change their labels to bring more…
-
Most Nephrogenic Systemic Fibrosis Cases Linked to 3 MRI Contrast Agents
Ominscan, Magnevist and Optimark are the three gadolinium-based MRI contrast agents associated with the highest number of nephrogenic systemic fibrosis (NSF) cases, according to new radiology industry safety standards.
-
Malpractice Lawsuit Over NSF From Gadolinium Considered Against Hospital
A Bermuda couple is planning to file a medical malpractice lawsuit against at U.S. hospital, claiming that doctors ignored FDA warnings and administered a gadolinium-based MRI contrast agent despite the…
-
Nephrogenic Systemic Fibrosis Settlements Reached by Bayer in 140 Cases
Bayer reports that it has reached settlement agreements with nearly half of the plaintiffs who have filed a Magnevist lawsuit, involving claims that the company’s gadolinium-based MRI contrasting agent caused…
-
GE Healthcare Settles Libel Lawsuit Over Omniscan with Radiologist
GE Healthcare and a Danish scientist have reached a settlement in a libel lawsuit over statements made about the side effects of Omniscan, an MRI contrast agent that has been…
